There is clear evidence for genetic intra-tumor heterogeneity in human PTCL: TET2 is mutated in a greater proportion of cases than RHOA and inspection of the published VAF results suggests sub-clonal variation in some cases [11,12]. Here, TET2 is linked to mature T-cell and NK-cell non-Hodgkin lymphoma.